Literature DB >> 23163601

An algorithm for genetic testing of Serbian patients with demyelinating Charcot-Marie-Tooth.

Milica P Keckarevic Markovic1, Jelena Dackovic, Jelena Mladenovic, Vedrana Milic-Rasic, Miljana Kecmanovic, Dusan Keckarevic, Stanka Romac.   

Abstract

Charcot-Marie Tooth (CMT) is a clinically and genetically heterogeneous group of diseases with rough genotype-phenotype correlation, so the final diagnosis requires extensive clinical and electrophysiological examination, family data, and gene mutation analysis. Although there is a common pattern of genetic basis of CMT, there could be some population differences that should be taken into account to facilitate analyses. Here we present the algorithm for genetic testing in Serbian patients with demyelinating CMT, based on their genetic specificities: in cases of no PMP22 duplication, and if -X-linked CMT (CMTX) is not contraindicated by pattern of inheritance (male-to-male transmission), one should test for c.94A>G GJB founder mutation, first. Also, when a patient is of Romani ethnicity, or if there is an autosomal recessive inheritance in a family and unclear ethnicity, c.442C>T mutation in NDRG1 should be tested.

Entities:  

Mesh:

Year:  2012        PMID: 23163601      PMCID: PMC3525895          DOI: 10.1089/gtmb.2012.0238

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  10 in total

1.  N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom.

Authors:  L Kalaydjieva; D Gresham; R Gooding; L Heather; F Baas; R de Jonge; K Blechschmidt; D Angelicheva; D Chandler; P Worsley; A Rosenthal; R H King; P K Thomas
Journal:  Am J Hum Genet       Date:  2000-05-30       Impact factor: 11.025

2.  Charcot-Marie-Tooth disease subtypes and genetic testing strategies.

Authors:  Anita S D Saporta; Stephanie L Sottile; Lindsey J Miller; Shawna M E Feely; Carly E Siskind; Michael E Shy
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

3.  Charcot-Marie-Tooth disease type I and related demyelinating neuropathies: Mutation analysis in a large cohort of Italian families.

Authors:  M L Mostacciuolo; E Righetti; M Zortea; V Bosello; F Schiavon; L Vallo; L Merlini; G Siciliano; G M Fabrizi; N Rizzuto; M Milani; S Baratta; F Taroni
Journal:  Hum Mutat       Date:  2001       Impact factor: 4.878

4.  Mutational analysis of GJB1, MPZ, PMP22, EGR2, and LITAF/SIMPLE in Serbian Charcot-Marie-Tooth patients.

Authors:  Milica Keckarevic-Markovic; Vedrana Milic-Rasic; Jelena Mladenovic; Jelena Dackovic; Miljana Kecmanovic; Dusan Keckarevic; Dusanka Savic-Pavicevic; Stanka Romac
Journal:  J Peripher Nerv Syst       Date:  2009-06       Impact factor: 3.494

5.  Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations.

Authors:  Chikahiko Numakura; Changqing Lin; Tohru Ikegami; Per Guldberg; Kiyoshi Hayasaka
Journal:  Hum Mutat       Date:  2002-11       Impact factor: 4.878

6.  Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients.

Authors:  I V Mersiyanova; S M Ismailov; A V Polyakov; E L Dadali; V P Fedotov; E Nelis; A Löfgren; V Timmerman; C van Broeckhoven; O V Evgrafov
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

7.  Genetic and clinical aspects of Charcot-Marie-Tooth's disease.

Authors:  H Skre
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

8.  Novel PCR-based diagnostic tools for Charcot-Marie-Tooth type 1A and hereditary neuropathy with liability to pressure palsies.

Authors:  E A Stronach; C Clark; C Bell; A Löfgren; N G McKay; V Timmerman; C Van Broeckhoven; N E Haites
Journal:  J Peripher Nerv Syst       Date:  1999       Impact factor: 3.494

9.  Screening of the early growth response 2 gene in Japanese patients with Charcot-Marie-Tooth disease type 1.

Authors:  Chikahiko Numakura; Emi Shirahata; Sumimasa Yamashita; Masayo Kanai; Kazuki Kijima; Takasumi Matsuki; Kiyoshi Hayasaka
Journal:  J Neurol Sci       Date:  2003-06-15       Impact factor: 3.181

10.  Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing.

Authors:  Sinead M Murphy; Matilde Laura; Katherine Fawcett; Amelie Pandraud; Yo-Tsen Liu; Gabrielle L Davidson; Alexander M Rossor; James M Polke; Victoria Castleman; Hadi Manji; Michael P T Lunn; Karen Bull; Gita Ramdharry; Mary Davis; Julian C Blake; Henry Houlden; Mary M Reilly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-05-10       Impact factor: 10.154

  10 in total
  1 in total

1.  Investigation of Mutations in Exon 14 of SH3TC2 Gene and Exon 7 of NDRG1 Gene in Iranian Charcot-Marie-Tooth Disease Type 4 (CMT4D) Patients.

Authors:  Rahmaneh Sadat Moosavi; Niloofar Jahangir Sooltani; Massoud Houshmand
Journal:  Iran J Child Neurol       Date:  2020
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.